Should Biotechnology Stock Spectrum Pharmaceuticals Inc (SPPI) Be in Your Portfolio Tuesday?

Tuesday, June 13, 2023 10:26 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Spectrum Pharmaceuticals Inc (SPPI) Be in Your Portfolio Tuesday?

A rating of 98 puts Spectrum Pharmaceuticals Inc (SPPI) near the top of the Biotechnology industry according to InvestorsObserver. Spectrum Pharmaceuticals Inc's score of 98 means it scores higher than 98% of stocks in the industry. Spectrum Pharmaceuticals Inc also received an overall rating of 89, putting it above 89% of all stocks. Biotechnology is ranked 17 out of the 148 industries.

SPPI has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on SPPI!

See Full SPPI Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 89 means the stock is more attractive than 89 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Spectrum Pharmaceuticals Inc Stock Today?

Spectrum Pharmaceuticals Inc (SPPI) stock is unmoved 0% while the S&P 500 is up 0.43% as of 10:24 AM on Tuesday, Jun 13. SPPI is unmoved $0.00 from the previous closing price of $1.04 on volume of 1,090,237 shares. Over the past year the S&P 500 has gained 16.22% while SPPI is up 35.06%. SPPI lost -$0.35 per share the over the last 12 months. Click Here to get the full Stock Report for Spectrum Pharmaceuticals Inc stock.